Search

Your search keyword '"Ewing, Nadia P."' showing total 20 results

Search Constraints

Start Over You searched for: Author "Ewing, Nadia P." Remove constraint Author: "Ewing, Nadia P." Database Supplemental Index Remove constraint Database: Supplemental Index
20 results on '"Ewing, Nadia P."'

Search Results

1. Venous Thromboembolism Risk Assessment and Prophylaxis Use in Pediatric, Adolescent, and Young Adult Hematology Oncology Patients

2. Cerebral Vasculopathy in Sickle Cell Anemia: Diagnostic Contribution of Positron Emission Tomography

3. Neutrophilic phagocytosis in autoimmune thrombocytopenia purpura

4. Hematologic Management of Hemophilia A for Surgery

5. Induction of Immune Tolerance to Factor VIII in Hemophiliacs With Inhibitors

7. Hemophilia A Inhibitor Subjects Show Unique PBMC Gene Expression Profiles That Include up-Regulated Innate Immune Modulators

8. Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia — A in the Sippet Cohort Study

9. Correlations of Plasma Cytokine Levels and Anti-FVIII Antibodies during Immune Tolerance Induction

11. Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia — A in the Sippet Cohort Study

12. Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

13. Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

14. Consequences of Switching From Prophylactic Treatment to On-Demand Treatment in Late Teens and Early Adults with Severe Hemophilia A. the TEEN/TWEN Study

15. International Consortium for the Study of Clinical and Molecular Aspects of Bernard-Soulier Syndrome

16. International Consortium for the Study of Clinical and Molecular Aspects of Bernard-Soulier Syndrome

18. A Phase II Open-Label Study Evaluating Hemostatic Activity, Pharmacokinetics and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Alloantibody Inhibitors Directed Against Human FVIII.

19. A Phase II Open-Label Study Evaluating Hemostatic Activity, Pharmacokinetics and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Alloantibody Inhibitors Directed Against Human FVIII.

20. Induction of Immune Tolerance in Hemophiliacs With Inhibitors-Reply

Catalog

Books, media, physical & digital resources